Interrelationship between cellular calcium homeostasis and free radical generation in myocardial reperfusion injury

Chemico-Biological Interactions

Volumn 104, Issue 2-3, 1997, Pages 65-85

  Bagchi, Debasis ^a   Wetscher, Gerold J ^a   Bagchi, Manashi ^a   Hinder, Paul R ^a   Perdikis, Galen ^a   Stohs, Sidney J ^a   Hinder, Ronald A ^a   Das, Dipak K ^b  

^a Departments of Surgery   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; FREE RADICAL; NIMODIPINE; NISOLDIPINE; OXYGEN RADICAL;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; REPERFUSION INJURY;

CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE; CLINICAL TRIALS; ELECTROPHYSIOLOGY; FATTY ACIDS, UNSATURATED; HOMEOSTASIS; HUMANS; HYDROGEN-ION CONCENTRATION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; PATIENT CARE PLANNING; PHOSPHOLIPIDS; REPERFUSION INJURY; SUPEROXIDES;

EID: 0031005304     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)03766-6     Document Type: Article

References (99)

1. A.C. Shen and R.B Jennings, Kinetics of calcium accumulation in acute myocardial ischemic injury. Am. J. Pathol., 67 (1972) 441-447.
2. 2+ in voltage-clamped rat heart cells: visualization with confocal microscopy. J. Physiol. (Lond), 480 (1994) 21-29.
3. D.K. Das and R.M. Engelman, Phospholipids in myocardial reperfusion injury, in: D.K. Das (Ed.), Pathophysiology of Reperfusion Injury, CRC Press, Boca Raton, 1991, pp. 149-170.
4. H. Otani, M.R. Prasad, R.M. Jones and D.K. Das, Mechanism of membrane phospholipid degradation in ischemic-reperfused rat hearts. Am. J. Physiol., 257 (1989) H252-H257.
5. S.W. Werns, M.J. Shea and B.R. Lucchesi, Free radicals and myocardial injury. Pharmacologic implications. Circulation, 74 (1986) 1-6.
6. D.K. Das and R.M. Engelman, Mechanism of free radical generation in ischemic and reperfused myocardium, in: D.K. Das, W.B. Essman (Eds.), Oxygen Radicals: Systemic Events and Disease Processes. Krager, Basel, Switzerland, 1989, pp. 97-127.
7. D.K. Das and N. Maulik, Antioxidant effectiveness in ischemia-reperfusion tissue injury. Methods Enzymol., 233 (1994) 601-610.
8. D.K. Das, R.M Engelman, J.A. Rousou, R.H. Breyer, H. Otani and S. Lemeshow, Pathophysiology of superoxide radical as potential mediator of ischemic and reperfusion injury in pig heart. Basic Res. Cardiol., 81 (1986) 155-166.
9. Y. Kimura, R.M. Engelman, J. Rousou, J. Flack, J. Iyengar and D.K. Das, Moderation of myocardial ischemia reperfusion injury by calcium channel and calmodulin receptor inhibition. Hearts Vessels, 7 (1992) 189-195.
10. X. Liu, R.M. Engelman, Z. Wei, D. Bagchi, J.A. Rousou, D. Nath and D.K. Das, Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines. Biochem Pharmacol., 45 (1993) 1333-1341.
11. D.K. Das, R.M. Engelman, R.M. Prasad, J.A. Rousou, R. Jones, H. Young, G.A. Cordis, Improvement of ischemia-reperfusion-induced myocardial dysfunction by modulating calcium overload using a novel, specific calmodulin antagonist, CGS 9343B. Biochem. Pharmacol., 38 (1989) 465-471.
12. A.J. Blackburn and K.J. Blackburn, Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. J. Mol. Cell Cardiol., 16 (1984) 427-433.
13. J.Y. Cheung, J.V. Bonventre, C.D. Malis, A. Leaf, Calcium and ischemic injury. N. Engl. J. Med., 314 (1986) 1670-1676.
14. S.R. Powell and D. Hall, Use of salicylate as a probe for OH. formation in isolated rat hearts. Free Rad. Biol. Med., 9 (1990) 133-141.
15. D.K. Das, G.A. Cordis, P.S. Rao, A. George, S. Maity, High performance liquid chromatographic detection of hydroxyl radical in heart. Its possible link with the myocardial reperfusion injury. J. Chromatogr., 536 (1991) 273-279.
16. C.M. Arroyo, J.H. Kramer, R.H. Leiboff, G.W. Mergner, B.F. Dickens and W.B. Weglicki, Spin trapping of oxygen and carbon-centered free radicals in ischemic canine myocardium. Free Rad. Biol. Med., 3 (1987) 313-320.
17. A. Tosaki, D. Bagchi, T. Pali, G.A. Cordis and D.K. Das, Comparisons of ESR and HPLC methods for the detection of OH. radicals in ischemic/reperfused hearts. Biochem. Pharmacol., 45 (1993) 961-969.
18. H. Otani, R.M. Engelman, J.A. Rousou, R.H. Breyer and D.K. Das, Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers. J. Mol. Cell. Cardiol., 18 (1986) 953-961.
19. 2+ pumps of coronary artery. Am. J. Physiol., 255 (1988) C297-C303.
20. T.F. Slater, Free-radical mechanisms in tissue injury. Biochem. J., 222 (1984) 1-15.
21. K.I. Shine, Ionic events in ischemia and anoxia. Am. J. Pathol., 102 (1981) 256-261.
22. H. Otani, R.M. Engelman, R.H. Breyer, J.A. Rousou, S. Lemeshow and D.K.Das, Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. J. Toracic. Cardiovasc. Surg., 92 (1986) 247-254.
23. D.K. Das, R.M. Engelman, J.A. Rousou, R.H. Breyer, H. Otani and S. Lemeshow, Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am. J. Physiol., 251 (1986) H71-H77.
24. T. Meyes, D. Holowka, L. Stryer, Highly cooperative opening of calcium channels by inositol 1,4,5-triphosphate. Science, 240 (1988) 653-656.
25. M. Inui, Y. Kimura, T. Sasaki and M. Tada, Molecular mechanism of calcium uptake and release by cardiac sarcoplasmic reticulum. Jpn. Circ. J., 54 (1990) 115-120.
26. 2+ mobilization without affecting the initial cleavage of phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets. FEBS Lett., 212 (1987) 123-126.
27. R.C. Inhorn, V.S. Bansal, P.W. Majerus, Pathway for inositol 1,3,4-troiphosphate and 1,4-biphosphate metabolism. Proc. Natl. acad. Sci. USA, 84 (1987) 2170-2174.
28. H. Otani, R. Prasad, R.M. Engelman, H. Otani, G.A. Cordis and D.K. Das, Enhanced phosphodiesteratic breakdown and turnover of phosphoinositides during reperfusion of ischemic rat heart. Circ. Res., 63 (1988) 930-936.
29. R. Prasad, L. Popescu, I. Moraru, X. Liu, R.M. Engelman and D.K. Das, Role of phospholipase A2 and phospholipase C in myocardial ischemic reperfusion injury. Am. J. Physiol., 260 (1991) H877-H883.
30. C.A. O'Brien, W.L. Arthur and I.B. Weinstein, The activation of protein kinase C by the polyphosphoinositides phosphatidylinositol-4-monophosphate. FEBS Lett., 214 (1987) 339-342.
31. H. Otani, R.M. Engelman, J.A. Rousou, R.H. Breyer and D.K. Das, Enhenced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. J. Mol. Cell. Cardiol., 18 (1986) 953-961.
32. Y. Kimura, J. Iyengar, R.M. Engelman and D.K. Das, Prevention of myocardial reperfusion injury in experimental coronary revascularization following ischemic arrest by a novel antiinflammatory drug, ONO-3144. J. Cardiovasc. Pharmacol., 16 (1990) 992-999.
33. D. Bagchi, J. Iyengar, P. Stockwell, D.K. Das, Enhanced prostaglandin production in the ischemic-reperfused myocardium by captopril linked with its free radical scavenging action. Prostaglandins Leukotrienes Essential Fatty Acids, 38 (1989) 145-150.
34. J.M. McCord, Oxygen-derived free radicals in post-ischemic tissue injury. N. Eng. J. Med., 312 (1985) 159-162.
35. D.K. Das, R.M. Engelman, R. Clement, H. Otani, M.R. Prasad and P.S. Rao, Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem. Biophys. Res. Commun., 148 (1987) 314-319.
36. J.H. Hill and P.A. Ward, C3 leukotactic factors produced by a tissue protease. J. Exp. Med., 133 (1971) 885-889.
37. R. Clement, D.K. Das, R.M. Engelman, H. Otani, D. Bandyopadhyay, S. Hoory, M. Antar, J.A. Rousou, R.H. Breyer and M.R. Prasad, Role of a nonateroidal antiinflammatory agent, ibuprofen, in coronary revascularization after acute myocardial infarction. Basic Res. Cardiol., 85 (1990) 55-70.
38. D.K. Das, R.M. Engelman, M. Bagchi and M.R. Prasad, Calcium uptake by sarcoplasmic reticulum and changes in membrane fluidity during free radical exposure, in: C. Rice-Evans (Ed.), Free Radical, Diseased States and Anti-Radical Interventions, Richeliew, London, 1989, pp. 431-466.
39. D.K. Das and A. Neogi, Effects of superoxide anions on the (Na+K) ATPase system in rat lung. Clin. Physiol. Biochem., 2 (1984) 32-38.
40. M. Bagchi, M.R. Prasad, R.M. Engelman and D.K. Das, Effects of free radicals on the fluidity of myocardial membranes. Free. Rad. Res. Commun., 7 (1989) 375-380.
41. R.M. Engelman, M.R. Prasad, J.A. Rousou, R.H. Breyer, M. Bagchi and D.K. Das, The mechanism of steroid-induced myocardial preservation following regional ischemia. Circulation, 80 (suppl III) (1989) 36-43.
42. D.K. Das, R.M. Engelman, D. Flansaas, H. Otani, J. Rousou, R.H. Breyer, Development profiles of protective mechanisms of heart against peroxidative injury. Basic. Res. Cardiol., 82 (1987) 36-50.
43. G.J. Gore, A.L. Miemienen, B.E. Wray, B. Harman, J.J. Lemasters, Intracellular pH during chemical hypoxia in cultured rat hepatocytes. J. Clin. Invest., 83 (1989) 386-396.
44. J.M. Bond; I.S. Harper; E. Chacon; J.M. Reece; B. Herman; Lemasters, J.J, The pH paradox in the pathophysaiology of reperfusion injury to rat neonatal cardiac myocytes. Annl. NY. Acad. Sci., 723 (1993) 25-37.
45. W.G. Nayler, F. Panagiopopoulon, J.F. Elz, M.J. Daily, Calcium-mediator damage during post-ischemic reperfusion. J. Mol. Cell. Cardiol., 20 (suppl II) (1988) 41-54.
46. W. Rouslin, Protonic inhibition of the mitochemical oligomycin-sensitive adenosine-5′-triphosphate in ischemic and autolyzing cardiac muscle. J. Biol. Chem., 258 (1983) 9657-9661.
47. J.L. Faber, K.R. Chien, S. Mittnacht, The pathogenesis of irreversible cell injury in ischemia. Am. J. Pathol., 102 (1981) 271-281.
48. R.A. Kloner, C.E. Ganote, D.A. Whalen, R.B, Jennings, Effect of transient period of ischemia on myocardial cells. Am. J. Pathol., 74 (1974) 399-407.
49. E. Morban, Y. Koretsune, M. Corretti, V.P. Chacko, H. Kusuoka, Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation, 80 (suppl IV) (1989) 17-22.
50. K. Nishioka, T. Nakanishi, J.M. Jarmakani, Effect of ischemia on calcium exchange in the rabbit myocardium. Am. J. Physiol., 247 (1984) H177-H 183.
51. H.C. Lee; R. Mohabir, N. Smith, M.R. Franz, W.T. Clusin, Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo 1. Circulation, 78 (1988) 1047-1055.
52. F. Lattanzio, Jr. Alterations, in intracellular free calcium and pH during global ischemia in the isolated perfused rat heart. Biophys. J., 53 (1988) 170a.
53. E. Marban, M. Kitakaze, H. Kusuoka, J.K. Porterfield, D.T. Yue, V.P. Ckacko, Intracellular free calcium concentration measured with 19F NMR spectroscopy in intact ferret hearts. Proc. Natl. Acad. Sci. USA, 84 (1987) 6005-6008.
54. R. Mohabir, H.C. Lee, R.W. Kruz, W.T. Clusin, Effects of ischemia and hypercarbic acidosis on myocyte calcium transients, contraction, and pH in perfused rabbit hearts. Circ. Res., 69 (1991) 1525-1537.
55. 2+ transients during open heart surgery: Hypothermic vs. normothermic cardioplegic arrest. Annl. NY Acad. Sci., 723 (1993) 229-238.
56. R. Zelis, R. Moore, Recent insights into the calcium channels. Circulation, 80 (suppl IV) (1989) 14-16.
57. Y. Kimura, R.M. Engelman, J. Rousou, J. Flack, J. Iyengar, D.K. Das, Moderation of myocardial ischemia reperfusion injury by calcium channel and calmodulin receptor inhibition. Heart Vessels, 7 (1992) 189-195.
58. T.H. Hintze, S.F. Vatner, Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs. Circ. Res., 52 (suppl I) (1983) 139-146.
59. T. Nagao, M.A. Matib, D. Franklin, R.W. Millard, A. Schwartz, Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion. J. Mol. Cell. Cardiol., 12 (1980) 29-43.
60. M. Tani, Mechanism of calcium overload in reperfused ischemic myocardiuym. Annu. Rev. Physiol., 52 (1990) 543-559.
61. S. Kooichi, M. Umeda, A. Itakura, Improvement of ischemic myocardial dysfunction by nisoldipine. Cardiovasac. Drug Ther., 8 (1994) 365-370.
62. X. Liu, R.M. Engelman, Z. Wei, D. Bagchi, J.A. Rousou, D. Nath, D.K. Das, Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines. Biochem. Pharmacol., 45 (1993) 1333-1341.
63. E.E. van der Wall, V.M. Cats, J.C. Chin, E.J.K. Pauwels, A.V.G. Bruschke, Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction. Cardiovasc. Drugs. Therap., 8 (1994) 345-351.
64. R.P. Karlsberg, P.D. Henry, S.A. Ahmed, B.E. Sobel, R. Roberts, Lack of protection of ischemic myocardium by verapamil in conscious dogs. Eur. J. Pharmacol., 42 (1977) 339-343.
65. A. Tosaki, L. Szekeres, D.J. Hearse, Diltiazem and the reduction of reperfusion-induced arrhythmias in the rat: protection is secondary to modification of ischemic injury and heart rate. J. Mol Cell. Cardiol., 19 (1987) 441-447.
66. P.D. Bourdillon, P.A. Poole-Wilson, The effect of verapamil, quiescence, and cardioplegia on calcium exchange and mechanical function in ischemic rabbit myocardium. Circ. Res., 50 (1982) 360-366.
67. G.H. Glitsch, H. Reuter, H. Scholz, The effect of internal sodium concentrationm on calcium fluxes in isolated guinea-pig auricles. J. Physiol. (Lond), 209 (1970) 25-32.
68. P.M. Grinwald, Calcium uptake during post-ischemic reperfusion in the isolated rat heart: influence of extracellular sodium. J. Mol. Cell. Cardiol., 14 (1982) 359-366.
69. P.M. Grinwald, C. Brosnahan, Sodium imbalance as a cause of calcium overload in post-hypoxic reoxygenation injury. J. Mol. Cell. Cardiol., 19 (1987) 487-495.
70. M. Karmazyn, Amiloride enhances postischemic ventricular recovery: possible role of Na+-H+ exchange. Am J. Physiol., 255 (1988) H608-H611.
71. R.G. Weiss, E.G. Lakatta, G. Gerstenblith, Effects of amiloride on metabolism and contractility during reoxygenation in perfused rat hearts. Circ. Res., 66 (1990) 1012-1017.
72. X. Liu, R.M. Engelman, J. Iyengar, G.A. Cordis, D.K. Das, Amiloride enhances postischemic ventricular recovery during cardioplegic arrest. Annl. N.Y. Acad. Sci., 639 (1991) 471-474.
73. J.G. Murphy, T.W. Smith, J.D. Marsh, Mechanism of reoxygenation-induced calcium overload in cultured chick embryo heart cells. Am J. Physiol., 254 (1988) H1133-H137.
74. 2+ and phorbol esters. Nature, 317 (1985) 546-548.
75. U. Ikeda, H. Arisaka, T. Takayasu, K. Takeda, N. Takashi, S. Hosoda, Protein kinase C activation aggrevates hypoxic myocardial injury by stimulating Na+/H+ exchange. J. Mol. Cell. Cardiol., 20 (1988) 493-498, 1988.
76. A.J. Higgins, K.J. Blackburn, Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. J. Mol. Cell. Cardiol., 16 (1984) 427-438.
77. K. Okumura, K. Ogawa, T. Satake, Effects of trofluoperazine and chlorpromazine on calcium-repleted injury in isolated ventricle strips. Basic Res. Cardiol., 80 (1985) 556-563.
78. K.R. Chien, J. Abrams, R.G. Pfau, J.C. Farben, Prevention by chlorpromazine of ischemic liver cell death. Am. J. Pathol., 88 (1977) 539-546.
79. H. Otani, R.M. Engelman, J.A. Rousou, R.H.Breyer, R. Clement, M.R. Prasad, J. Klar, D.K. Das, Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization. J. Thoracic. Cardiovasc. Surg., 87 (1989) 267-275.
80. D.K. Das, R.M. Engelman, M.R. Prasad, J.A. Rousou, R.H. Breyer, R. Jones, H. Young, G.A. Cordis, Improvement of ischemia-reperfusion-induced myocardial dysfunction by modulating calcium overload using a novel, specific calmodulin antagonist, CGS 9343B. Biochem. Pharmacol., 38 (1989) 465-471.
81. A.J.B. Brady, J.B. Warren, P.A. Poole-Wilson, T.J. Williams, S.E. Harding, Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol., 265 (1993) H176-H182.
82. U. Forstermann, J.S. Pollock, H.H.H. Schmidt, M. Heller, F. Murad, Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci, USA, 88 (1991) 1788-1792.
83. X. Xu, R.A. Star, G. Tortorici, S. Muallem, Depletion of intracellular Ca stores activates nitric-oxide synthase to generate cGMP and regulate Ca influx. J. Biol. Chem., 269 (1994) 12645-12653.
84. S. Pou, W.S. Pou, D.S. Bredt, S.H. Snyder, G.M. Rosen, Generation of superoxide by purified nitric oxide synthase. J. Biol. Chem., 267 (1992) 24173-24176.
85. R.G. Knowles, M. Palacios, R.M.J. Palmer, S.Moncada, Formation of nitric oxide from L-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci., USA, 86 (1989) 5159-5162.
86. U. Forstermann, U.H.H.H.W, J.S. Pollock, H. Sheng, J.A. Mitchell, T.D. Warner, M. Nakane, F. Murad, Isoforms of nitric oxide synthase: Characterization and purification from different cell types. Biochem. Pharmacol., 42 (1991) 1849-1857.
87. M.L. Jordan, B. Rominski, A. Jaquins-Gerstl, D.Geller, R.A. Hoffman, Regulation of inducible nitric oxide production by intracellular calcium. Surgery, 118 (1995) 138-146.
88. L.G. Meszaros, I. Minarovic, A. Zahradnikova, Inhibition of the skeletal muscle ryanodine receptor calcium release channel ny nitric oxide. FEBS Lett., 380 (1996) 49-52, 1996.
89. M.S. Finkel, C.V. Oddis, T.D. Jacob, S.C. Watkins, B.G. Hattler, R.L. Simmons, Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science, 257 (1992) 387-389.
90. M. Previtali, R. De Ponti, C. Storti, C. Panciroli, J.A. Salerno, Hemodynamic effects of nisoldipine in acute myocardial infarction, in: P.R. Lichtlen, P.G. Hugenholz (Eds.) Nisoldipine. Stuttgart: schattauer, (1988) 142-152.
91. J. Wilson, P.J. Commerford, R.S. Miller, L.H. Opie, Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction. Cardiovasc. Drug. Therp., 6 (1992) 41-46.
92. P.H. Held, S. Yusuf, C. Furberg, Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT II) and other recent studies. Am. J. Crdiol., 67 (1991) 1295-1297.
93. P.A. Sirnes, K. Overskeid, T.R. Pederson, J. Bathen, A. Drivenes, G.S. Froland, J.K. Kjekshus, K. Landmark, R. Rokseth, K.E. Sirnes, A. Sundoy, B.R. Torjussen, Westlund KM, Wik BA, Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction. The Norwegian Multicenter Trial. Circulation, 4 (1984) 638-644.
94. R.G. Wilcox, J.R. Hampton, D.C. Banks, J.S. Birkhead, I.A.B. Brooksby, C.J. Burnscox, M.J. Hayes, M.D. Joy, A.D. Malcolm, H.G. Mather, J.M. Rowley, Trial of early nifedipine in acute myocardial infarction: the Trent study. Br. Med J., 293 (1986) 1204-1208.
95. The Israeli SPRINT study group. A randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur. Heart. J., 9 (1988) 354-364.
96. The multicenter diltiazem postinfarction trial research group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N. Eng J. Med., 319 (1988) 385-392.
97. The Danish study group on verapamil in myocardial infarction. effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIL II). Am. J. Cardiol., 66 (1990) 779-785.
98. B.M. Psaty, S.R. Heckbert, T.D. Koepsell, D.S. Siscovick. T.E. Raghunathan, N.S. Weiss, F.R. Rosendaal, R.N. Lemaitre, N.L. Smith, P.W. Wahl. E.H. Wagner, C.D. Furberg, The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA., 274 (1995) 620-625.
99. P.R. Lichtlen, P.G. Hugenholtz, W. Rafflenbeul, Retardation of angiographic progression of coronary artery disease by ifedipine: results of the International nifedipine trial on antiatherosclerotic therapy (INTACT). Lancet, 335 (1990) 1109-1113.